Barisoni, L., Barratt, J., Campbell, K., Eva, L., Gillespie, B. S., Gipson, D., … Rovin, B. H. (2021). Innovating and invigorating the clinical trial infrastructure for glomerular diseases. Kidney Int, 99(3), 519–523. https://doi.org/10.1016/j.kint.2020.09.038

Barisoni, Laura, Jonathan Barratt, Kirk Campbell, Lauren Eva, Barbara S. Gillespie, Debbie Gipson, Tobias Huber, et al. “Innovating and invigorating the clinical trial infrastructure for glomerular diseases.” Kidney Int 99, no. 3 (March 2021): 519–23. https://doi.org/10.1016/j.kint.2020.09.038.

Barisoni L, Barratt J, Campbell K, Eva L, Gillespie BS, Gipson D, et al. Innovating and invigorating the clinical trial infrastructure for glomerular diseases. Kidney Int. 2021 Mar;99(3):519–23.

Barisoni, Laura, et al. “Innovating and invigorating the clinical trial infrastructure for glomerular diseases.” Kidney Int, vol. 99, no. 3, Mar. 2021, pp. 519–23. Pubmed, doi:10.1016/j.kint.2020.09.038.

Barisoni L, Barratt J, Campbell K, Eva L, Gillespie BS, Gipson D, Huber T, Jardine M, Kamil E, Kretzler M, Lee L, Levtchenk E, Mehr AP, Nachman PH, Oh J, Saleem M, Shankland SJ, Smith K, Smokler I, Smoyer W, Tarnoff J, Thompson A, Trachtman H, Udani S, Vivarelli M, Walker P, West M, Rovin BH. Innovating and invigorating the clinical trial infrastructure for glomerular diseases. Kidney Int. 2021 Mar;99(3):519–523.